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Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a
rare, fatal disorder, presenting with fever, cytopenia,
liver dysfunction, hepatosplenomegaly, hypertriglyc-
eridemia, and hyperferritinemia.1 Accumulation in the
reticuloendothelial system of activated macrophages
showing phagocytosis of hematopoietic cells is the
characteristic histologic finding. HLH may be primary,
as observed in familial HLH, X-linked lymphoprolif-
erative syndrome, and Chediak-Higashi syndrome,2 or
it may be secondary to malignancies, infections, auto-
immune diseases, or drugs.3 Malignancy, particularly
lymphoma, and Epstein-Barr virus (EBV) infection are
the leading causes of adult HLH.3 Pregnancy-induced
HLH has only been reported in a few cases.4 Here,
we report a case of pregnancy-induced HLH combined
with autoimmune hemolytic anemia (AIHA). Both
the HLH and AIHA did not respond to steroid treat-
ment, but spontaneously recovered after pregnancy
termination.
Case Report
A 28-year-old woman was admitted to the hospital at
23 weeks of gestation in her first pregnancy after fever
up to 39°C of 2 weeks’ duration. She had been healthy
prior to this fever. Her complete blood count was
within normal range at the 10th week of gestation. Her
blood pressure on admission was 118/64 mmHg, with
regular heart beat. Physical examination revealed no
skin rash, no arthritis, but palpable liver and spleen,
which were 3 cm and 4 cm below the right and left
subcostal regions, respectively. Infection surveys in-
cluding blood culture, urine culture, chest X-ray, and
abdominal magnetic resonance imaging were made.
Hepatosplenomegaly and mild right-side hydroneph-
rosis were the noted abnormalities. Serial laboratory
examinations were done. The patient’s white blood
cell count was 8.9 × 109/L, with 92% neutrophils and
7% lymphocytes. Her red blood cell count, hemo-
globin, and mean corpuscular volume were 2.63 ×
1012/L, 7.4 g/dL, and 84 fL, respectively. She also had 
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thrombocytopenia. Her platelet count was 109×109/L.
Serum aspartate transaminase and alanine transaminase
for liver function were 92 IU/L and 18 IU/L, respec-
tively. Blood urea nitrogen and serum creatinine for
renal function were 9 mg/dL and 0.7 mg/dL. Her
lactate dehydrogenase (LDH) was extremely high, at
1,760 IU/L (normal, 120–240 IU/L). In hemostasis
tests, prothrombin time and activated partial thrombo-
plastin time were 13.4 seconds (control, 11.5 seconds)
and 31.4 seconds (control, 30.0 seconds), respectively.
Tests for autoimmune disease, including antinuclear and
anticardiolipin antibodies, were negative. Serum tri-
glyceride level (386 mg/dL; normal, 20–200 mg/dL),
ferritin (8,926ng/mL; normal, 6–81ng/mL), and sol-
uble interleukin-2 receptor (2,892 pg/mL; normal,
< 880 pg/mL) were elevated. Bone marrow examina-
tion revealed marked hemophagocytosis (Figure 1).
Peripheral blood smear showed no prominent schizo-
cytes. Microangiopathic hemolytic anemia was excluded
because there were no impaired renal function and no
peripheral blood fragmented red blood cells, and the
patient’s disseminated intravascular coagulopathy pro-
files were negative. In addition, without arthritis and
skin rash, adult-onset Still’s disease was less likely.
Diagnosis of HLH was by fulfillment of the criteria 
of fever, cytopenia, elevated LDH, hyperferritinemia,
hepatosplenomegaly, and hemophagocytosis in bone
marrow.1 Viral serology tests for EBV, herpes simplex
virus, and hepatitis B were negative. Real-time quan-
titative polymerase chain reaction also did not detect
EBV DNA. Fever subsided after treatment with intra-
venous methasone 5 mg every 6 hours per day for 
2 days, but anemia and thrombocytopenia persisted.
Repeated bone marrow examination continued to
reveal profound hemophagocytosis. Because the fever
had subsided, the patient only accepted follow-up with-
out any medication. During this period of time, she still
had anemia, with hemoglobin of around 8 g/dL.
At 28 weeks of gestation, the patient suffered from
a sudden onset of dyspnea on exertion, plus icteric
sclera and tea-colored urine. Her hemoglobin dropped
from 7.8 g/dL to 4.9 g/dL, with relatively stable plate-
let count (245 × 109/L). Positive direct and indirect
antiglobulin tests, decreased haptoglobulin (< 5.8 mg/
dL; normal, 20–200mg/dL), and elevated reticulocyte
count (13.73%; normal, 0.5–1.5%) indicated AIHA.
Serum alloantibody screening test was negative. Her
tea-colored urine and anemia persisted despite treat-
ment with methasone. For the safety of the fetus, only
packed red blood cell transfusion and adequate hydra-
tion were given.
At 29 weeks of gestation, because of decreasing
fetal movement, the patient delivered a 740-g girl by
cesarean section. The baby died at 3 days of age from
pulmonary distress. Three days after delivery, the
patient’s serum ferritin, LDH, and complete blood
count improved. Four weeks after delivery, repeated
bone marrow examination revealed no hemophago-
cytosis. Blood tests revealed no anemia, no thrombo-
cytopenia, normal LDH, and a negative antiglobulin
test. Two years after this episode, the patient delivered
a healthy girl without any complications.
Discussion
HLH is associated with a variety of viral, bacterial, fun-
gal, and parasitic infections, as well as with collagen vas-
cular diseases and malignancies, especially lymphoma.3,5
For patients with HLH, it is important to survey every
possible etiology because the underlying diseases
strongly affect the treatment and outcome of HLH.
Due to the rarity of HLH and it having similar clinical
presentations to microangiopathic hemolytic anemia
and adult-onset Still’s disease, such as fever of unknown
origin, cytopenia and extremely elevated serum ferritin,
HLH is easily missed during pregnancy. There are only
a few cases of pregnancy-related HLH in the reviewed
literature.4 In these published cases, however, it was
unclear as to whether it was the pregnancy itself, EBV
infection, or even both, that were responsible for the
HLH. Pregnancy-induced HLH without evidence of
EBV infection and other identified etiologies, combined
with AIHA, has rarely been reported previously.
The pathophysiology of HLH is not completely
understood, not to mention its relation to pregnancy.
Figure 1. Bone marrow aspiration smear reveals activated
macrophages with phagocytosis of hematopoietic cells, including
mature red blood cells, nucleated red blood cells, lymphocytes,
and neutrophils (arrows). (Wright and Giemsa stain, 400×.)
A cytokine storm is believed to be responsible for
HLH. Osugi et al6 hypothesized that activated Th1
lymphocytes secrete interferon-γ, stimulating macro-
phages. Stimulated and uncontrolled macrophages
result in phagocytosis of hematopoietic cells and rapid
production of tissue necrosis factor-α, initiating the
inflammatory effector pathway, resulting in fever,
hyperferritinemia, and other associated symptoms.7
According to these proposed mechanisms, different
T-cell regulations adapted to pregnancy must play
important roles in pregnancy-induced HLH. During
normal pregnancy, T helper lymphocytes typically
shift from Th1 to Th2 dominance because of immune
adaptation to the genetically foreign fetus and anti-
genicity.8 Elevated Th1/Th2 ratio in pregnancy induces
recurrent pregnancy losses, failure of implantation,
and preeclampsia.9
In this patient, we hypothesized that fetomaternal
trafficking was the key element in pregnancy-induced
HLH and its cytokine storm. The evidence came
from preeclampsia. Preeclampsia is a form of maternal
immune rejection of the genetically foreign fetus due
to unsuccessful maternal T-lymphocyte recognition of
fetomaternal human lymphocyte antigens.10 Immature
placenta releases trophoblast debris, including syncy-
tiotrophoblast components, soluble RNA and DNA
of fetal origin, and even cytotrophoblast cells, into
the maternal circulation. This fetomaternal trafficking
induces a profound systemic inflammatory response,
mimicking pregnancy-induced HLH.11
AIHA is also uncommon during pregnancy.
Increased red blood cell autoantibody production
during pregnancy has been reported, but rarely causes
clinically significant symptoms.12 In addition, the clini-
cal spectra among general patients with red blood cell
autoantibodies vary from no signs to severe hemolysis.
It is believed that profound inflammatory cytokines
produced by the mononuclear phagocytic system par-
ticipate in the destruction of opsonized erythrocytes.13
Further study demonstrated that monocyte monolayer
assay activity and in vitro cytokine production may re-
flect the in vivo activity of autoantibodies and sequen-
tial AIHA.14 According to these studies, we believe that
an activated phagocyte system and cytokine overpro-
duction in HLH were responsible for the severe AIHA
in this patient.
Treatment guidelines for pregnancy-induced HLH
and AIHA have not been established. Steroids are gen-
erally the first treatment option for both HLH and
AIHA.15,16 Our patient, however, was not responsive
to steroid treatment. Prognosis of secondary HLH is
usually poor and largely depends on the underlying
diseases. Etoposide-based chemotherapy is almost
always required for aggressive HLH.15 The use of
chemotherapy in pregnant women, however, is a big
challenge because of its toxicities and potential ter-
atogenic effects. Even though successful delivery has
been reported for women who had received chemo-
therapeutic agents during pregnancy,17 in this case,
etoposide was not used for aggressive HLH because
of the risks to both the mother and fetus. In addition
to conventional therapies, novel treatments such as
rituximab have been increasingly applied to auto-
immune hematologic diseases.18 For patients with
lymphoma-associated HLH, rituximab might be help-
ful as well.19 It remains unclear, however, if rituximab
is effective for pregnancy-induced HLH.
The baby eventually died of complications arising
from its retarded growth and immaturity. The mother
completely recovered within 3 days after the termina-
tion of pregnancy. In this case, for both the mother
and fetus, early termination of pregnancy appeared 
to be of greater benefit than treatment with steroid
and chemotherapeutic agents. The patient had a nor-
mal pregnancy and delivery 2 years after this event,
which indicated that pregnancy-induced HLH might
be accidental.
In conclusion, we have reported a rare case of
pregnancy-induced HLH combined with AIHA.
Fetomaternal trafficking probably induced the cytokine
storm in this genetically susceptible pregnant woman
that may have caused the disease. Termination of preg-
nancy might be a distinct therapeutic option for such a
situation. The differential diagnosis of pregnant women
with fever and cytopenia should include HLH.
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